Published in N Engl J Med on September 30, 1999
Effects of Omega-3 Fatty Acids on Bone and Frailty | NCT00634686
Case records of the Massachusetts General Hospital. Case 16-2013. A 12-year-old girl with irritability, hypersomnia, and somatic symptoms. N Engl J Med (2013) 2.60
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ (2003) 1.63
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A (2000) 1.51
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2016) 1.43
Hormonal regulation of longevity in mammals. Ageing Res Rev (2007) 1.15
Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab (2007) 1.08
Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol (2013) 1.04
Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care (2002) 0.99
Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol (2015) 0.97
Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc Natl Acad Sci U S A (2001) 0.96
Endocrine alterations in response to calorie restriction in humans. Mol Cell Endocrinol (2008) 0.95
Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes (2010) 0.93
Dehydroepiandrosterone and age-related cognitive decline. Age (Dordr) (2009) 0.93
Androgen therapy with dehydroepiandrosterone. World J Urol (2003) 0.87
A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study. Psychopharmacology (Berl) (2006) 0.87
Multisteroid LC-MS/MS assay for glucocorticoids and androgens, and its application in Addison's disease. Endocr Connect (2013) 0.85
A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res (2013) 0.85
Pharmacologically induced hypogonadism and sexual function in healthy young women and men. Neuropsychopharmacology (2008) 0.83
Off-label use of hormones as an antiaging strategy: a review. Clin Interv Aging (2014) 0.82
Sexual desire disorders. Psychiatry (Edgmont) (2008) 0.80
The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated. PLoS One (2015) 0.80
[Hypopituitarism]. Internist (Berl) (2004) 0.80
A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio. J Mol Endocrinol (2012) 0.80
Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res (2001) 0.78
A Comparative Study of CEE, Tibolone, and DHEA as Hormone Replacement Therapy for Surgical Menopause. J Obstet Gynaecol India (2012) 0.76
Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone. J Neurol (2005) 0.76
Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients. Endocrinol Diabetes Metab Case Rep (2015) 0.76
Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo Clin Proc (2008) 0.76
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions. Front Psychol (2017) 0.75
Dehydroepiandrosterone for adrenal insufficiency. N Engl J Med (1999) 0.75
Endocrine and metabolic changes in human aging. J Am Aging Assoc (2000) 0.75
Addisonian crisis in a young man with atypical anorexia nervosa. Nat Rev Endocrinol (2010) 0.75
Delayed diagnosis of Addison's disease: an approach to management. BMJ Case Rep (2014) 0.75
Hyponatremia and seizures caused by triamcinolone-induced adrenal insufficiency. Nat Rev Nephrol (2010) 0.75
The steroid metabolome in the isolated ovarian follicle and its response to androgen exposure and antagonism. Endocrinology (2017) 0.75
Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine (2017) 0.75
Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med (1999) 2.87
Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75
Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol (2001) 2.56
Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest (2001) 2.35
Thymic nurse cells. Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization. J Exp Med (1980) 2.23
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev (1996) 2.11
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex (2000) 2.04
[Bilateral salivary gland swelling with pitfalls]. Med Klin (Munich) (1994) 2.03
Adrenal-sparing surgery for phaeochromocytoma. Br J Surg (1999) 1.96
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J (2007) 1.81
High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol (2001) 1.74
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
The 'incidentaloma' of the pituitary gland. Is neurosurgery required? JAMA (1990) 1.65
A review of tobacco smoking in adolescents: treatment implications. J Am Acad Child Adolesc Psychiatry (2000) 1.63
Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol (1994) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med (2013) 1.57
Low circulating androgens and mortality risk in heart failure. Heart (2009) 1.56
Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest (1992) 1.55
Detection of doping with human growth hormone. Lancet (1999) 1.55
Adiabatic dipolar recoupling in solid-state NMR: the DREAM scheme. J Magn Reson (2001) 1.53
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood (2000) 1.52
Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol (1993) 1.49
Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2009) 1.45
Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J (2007) 1.44
Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol (1994) 1.43
Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood monocytes. Eur J Immunol (2001) 1.42
Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res (2010) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia (2007) 1.41
Fatal toxic epidermal necrolysis during suramin therapy. Eur J Cancer (1991) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
[Therapy-resistant hypertension--the endocrinological view]. MMW Fortschr Med (2007) 1.39
Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect Immun (1994) 1.39
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes. Microbes Infect (2000) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2011) 1.34
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry (2010) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer (1999) 1.31
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab (2009) 1.30
Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J Clin Pathol (1991) 1.30
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol (2000) 1.29
Methods for sequential resonance assignment in solid, uniformly 13C, 15N labelled peptides: quantification and application to antamanide. J Biomol NMR (2001) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology (1984) 1.26
Solid-state NMR studies of the prion protein H1 fragment. Protein Sci (1996) 1.25
Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun (1996) 1.25
Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int J Tuberc Lung Dis (2008) 1.24
Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer (2000) 1.23
Superoxide release by zymosan-stimulated rat Kupffer cells in vitro. Eur J Biochem (1981) 1.23
An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models. Curr Med Chem (2007) 1.22
Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab (1992) 1.16
Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer (1999) 1.16
DNA polymorphisms in adhesion molecule genes--a new risk factor for early atherosclerosis. Hum Genet (1996) 1.16
Self-injury in Lesch-Nyhan disease. J Autism Dev Disord (1994) 1.16
Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet (1990) 1.15
Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences. Proc Natl Acad Sci U S A (1988) 1.15
Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol (2001) 1.15
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J (2006) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) (1990) 1.13
Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect Immun (1996) 1.13
Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol (1994) 1.13
Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol Cell Biol (1990) 1.12
Oxytocin increases anxiety to unpredictable threat. Mol Psychiatry (2012) 1.12
Clonal composition of human adrenocortical neoplasms. Cancer Res (1994) 1.10
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci U S A (1994) 1.09
Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun (1995) 1.09
Physiological and psychological effects of Hatha-Yoga exercise in healthy women. Int J Psychosom (1994) 1.09
Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab (2004) 1.08
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol (2012) 1.08
Ultrasound diagnosis and neurodevelopmental outcome of localised and extensive cystic periventricular leucomalacia. Arch Dis Child Fetal Neonatal Ed (2001) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Appetitive conditioning: neural bases and implications for psychopathology. Neurosci Biobehav Rev (2007) 1.07
Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab (1998) 1.06
Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab (1990) 1.06
Interleukin-12 as successful adjuvant in tuberculosis treatment. Eur Respir J (2001) 1.06
Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology (1996) 1.06
Low medial prefrontal dopaminergic activity in autistic children. Lancet (1997) 1.06
Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology (2000) 1.06
[Multimorbidity and successful aging: the population-based KORA-Age study]. Z Gerontol Geriatr (2011) 1.05
Adrenal tumors: how to establish malignancy ? J Endocrinol Invest (2004) 1.05